chr8-142875277-G-A

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_000497.4(CYP11B1):​c.1157C>T​(p.Ala386Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0409 in 1,603,440 control chromosomes in the GnomAD database, including 6,424 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A386E) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.054 ( 723 hom., cov: 33)
Exomes 𝑓: 0.040 ( 5701 hom. )

Consequence

CYP11B1
NM_000497.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.420

Publications

26 publications found
Variant links:
Genes affected
CYP11B1 (HGNC:2591): (cytochrome P450 family 11 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
GML (HGNC:4375): (glycosylphosphatidylinositol anchored molecule like) Predicted to be involved in DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; apoptotic process; and negative regulation of cell population proliferation. Predicted to be extrinsic component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 6 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 1 uncertain in NM_000497.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 45 curated pathogenic missense variants (we use a threshold of 10). The gene has 9 curated benign missense variants. Gene score misZ: -1.5619 (below the threshold of 3.09). Trascript score misZ: -0.26962 (below the threshold of 3.09). GenCC associations: The gene is linked to glucocorticoid-remediable aldosteronism, congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency.
BP4
Computational evidence support a benign effect (MetaRNN=0.0053716004).
BP6
Variant 8-142875277-G-A is Benign according to our data. Variant chr8-142875277-G-A is described in ClinVar as Benign. ClinVar VariationId is 362149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP11B1NM_000497.4 linkc.1157C>T p.Ala386Val missense_variant Exon 7 of 9 ENST00000292427.10 NP_000488.3
CYP11B1NM_001026213.1 linkc.1157C>T p.Ala386Val missense_variant Exon 7 of 8 NP_001021384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP11B1ENST00000292427.10 linkc.1157C>T p.Ala386Val missense_variant Exon 7 of 9 1 NM_000497.4 ENSP00000292427.5

Frequencies

GnomAD3 genomes
AF:
0.0537
AC:
8110
AN:
151134
Hom.:
719
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0444
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.105
Gnomad ASJ
AF:
0.0309
Gnomad EAS
AF:
0.429
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.0261
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0188
Gnomad OTH
AF:
0.0582
GnomAD2 exomes
AF:
0.0784
AC:
19408
AN:
247626
AF XY:
0.0764
show subpopulations
Gnomad AFR exome
AF:
0.0418
Gnomad AMR exome
AF:
0.131
Gnomad ASJ exome
AF:
0.0238
Gnomad EAS exome
AF:
0.425
Gnomad FIN exome
AF:
0.0250
Gnomad NFE exome
AF:
0.0159
Gnomad OTH exome
AF:
0.0547
GnomAD4 exome
AF:
0.0396
AC:
57472
AN:
1452188
Hom.:
5701
Cov.:
35
AF XY:
0.0421
AC XY:
30458
AN XY:
722634
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0395
AC:
1309
AN:
33178
American (AMR)
AF:
0.128
AC:
5660
AN:
44092
Ashkenazi Jewish (ASJ)
AF:
0.0237
AC:
618
AN:
26064
East Asian (EAS)
AF:
0.432
AC:
16771
AN:
38820
South Asian (SAS)
AF:
0.138
AC:
11775
AN:
85138
European-Finnish (FIN)
AF:
0.0264
AC:
1407
AN:
53312
Middle Eastern (MID)
AF:
0.0347
AC:
189
AN:
5452
European-Non Finnish (NFE)
AF:
0.0151
AC:
16653
AN:
1106394
Other (OTH)
AF:
0.0517
AC:
3090
AN:
59738
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.380
Heterozygous variant carriers
0
1971
3941
5912
7882
9853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0537
AC:
8121
AN:
151252
Hom.:
723
Cov.:
33
AF XY:
0.0593
AC XY:
4388
AN XY:
73966
show subpopulations
African (AFR)
AF:
0.0443
AC:
1806
AN:
40800
American (AMR)
AF:
0.105
AC:
1605
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0309
AC:
107
AN:
3468
East Asian (EAS)
AF:
0.430
AC:
2172
AN:
5054
South Asian (SAS)
AF:
0.155
AC:
743
AN:
4800
European-Finnish (FIN)
AF:
0.0261
AC:
277
AN:
10612
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0188
AC:
1281
AN:
67964
Other (OTH)
AF:
0.0595
AC:
125
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
311
623
934
1246
1557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
13
Bravo
AF:
0.0588
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0202
AC:
78
ESP6500AA
AF:
0.0390
AC:
172
ESP6500EA
AF:
0.0170
AC:
146
ExAC
AF:
0.0765
AC:
9291

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Deficiency of steroid 11-beta-monooxygenase Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Apr 20, 2020
Department of Human Genetics, Laborarztpraxis Dres. Walther, Weindel und Kollegen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Glucocorticoid-remediable aldosteronism Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.8
DANN
Benign
0.75
DEOGEN2
Benign
0.0083
T;T;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.00087
N
LIST_S2
Benign
0.13
T;T;T;T
MetaRNN
Benign
0.0054
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-2.1
.;N;N;.
PhyloP100
0.42
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
2.0
N;N;N;N
REVEL
Benign
0.13
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
1.0
T;T;T;T
Polyphen
0.0
.;B;.;B
Vest4
0.043, 0.049
MPC
0.084
ClinPred
0.0014
T
GERP RS
1.9
Varity_R
0.070
gMVP
0.83
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4541; hg19: chr8-143956693; COSMIC: COSV52830014; API